Cocrystal Pharma Company Insiders
| COCP Stock | USD 2.29 0.18 8.53% |
Cocrystal Pharma employs about 12 people. The company is managed by 4 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 3.0 employees per reported executive. Discussion of Cocrystal Pharma's management performance can provide insight into the enterprise performance.
| Sam Lee Founder Co-Founder and Pres |
Cocrystal |
Cocrystal Pharma's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Cocrystal Pharma's future performance. Based on our forecasts, it is anticipated that Cocrystal will maintain a workforce of slightly above 12 employees by January 2025.Cocrystal Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.4606) % which means that it has lost $0.4606 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6886) %, meaning that it created substantial loss on money invested by shareholders. Cocrystal Pharma's management efficiency ratios could be used to measure how well Cocrystal Pharma manages its routine affairs as well as how well it operates its assets and liabilities. As of 12/19/2024, Return On Tangible Assets is likely to drop to -0.6. In addition to that, Return On Capital Employed is likely to drop to -0.7. As of 12/19/2024, Non Current Liabilities Other is likely to grow to about 366.4 K, while Total Current Liabilities is likely to drop slightly above 2.7 M.As of 12/19/2024, Common Stock Shares Outstanding is likely to grow to about 13.1 M, while Net Loss is likely to drop (36.7 M).
Cocrystal Pharma Workforce Comparison
Cocrystal Pharma is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 66,719. Cocrystal Pharma adds roughly 12.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Cocrystal Pharma Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cocrystal Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cocrystal Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cocrystal Pharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2023-06-01 | 1.0 | 1 | 1 | 1,015,229 | 0.00 |
| 2020-06-01 | 7.0 | 7 | 1 | 678,000 | 150,000 |
| 2018-06-01 | 2.5 | 5 | 2 | 1,062,525 | 324,886 |
| 2017-09-01 | 1.0 | 1 | 1 | 1,706,978 | 1,706,978 |
| 2015-03-01 | 2.1667 | 13 | 6 | 402,366,159 | 55,001,480 |
Cocrystal Pharma Notable Stakeholders
A Cocrystal Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cocrystal Pharma often face trade-offs trying to please all of them. Cocrystal Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cocrystal Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Sam Lee | Co-Founder and Pres | Profile | |
| Roger Kornberg | Independent CoFounder | Profile | |
| Prof Kornberg | Independent CoFounder | Profile | |
| CPA CPA | CFO CoCEO | Profile |
About Cocrystal Pharma Management Performance
The success or failure of an entity such as Cocrystal Pharma often depends on how effective the management is. Cocrystal Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cocrystal management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cocrystal management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.58) | (0.60) | |
| Return On Capital Employed | (0.66) | (0.70) | |
| Return On Assets | (0.58) | (0.60) | |
| Return On Equity | (0.68) | (0.65) |
Cocrystal Pharma Workforce Analysis
Traditionally, organizations such as Cocrystal Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cocrystal Pharma within its industry.Cocrystal Pharma Manpower Efficiency
Return on Cocrystal Pharma Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.5M | |
| Net Loss Per Executive | 4.5M | |
| Working Capital Per Employee | 2.2M | |
| Working Capital Per Executive | 6.5M |
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.